Ambev is trading at $3.16, down 4.8% in pre-market; the catalyst remains unconfirmed. - Available search results identified no fresh company-specific announcement explaining the decline. - Ambev’s next scheduled third-quarter results are October 29, not October 21. - Major U.S. indexes were mixed to slightly higher, so broad-market weakness does not clearly explain the move.